High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Items 701–750 of 750
Williams, F. S., Zaniletti, I., Schwartz, L. F., Garofalo, R., Kuhns, L. M., Felsher, K., Liu, Y., & Simon, M. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23091145
HogenEsch, E., & Huddleston, H. G. (2026) · Fertility and Sterility · doi:10.1016/j.fertnstert.2026.08.1133
Quiñones-Lara, E. (2026) · The Journal of Reproduction · doi:10.58779/tjorvol4num1/6
Navarro-Pando, J. M. (2026) · The Journal of Reproduction · doi:10.58779/tjorvol4num1/3
Dong, P., Tang, Y., Wang, T., Xue, Y., Ying, X., & Jin, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1904708
夏, 丽. (2026) · Traditional Chinese Medicine · doi:10.12677/tcm.2026.159503
Ultrasound-Based Assessment of Ovarian Volume and Follicle Numbers in Lean and Obese PCOS Women
Omar, N. S., Hussein, S. A., Shah, L. J. A., & Abdulkareem, N. K. (2026) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.24200/jogcr.11.11.1047
Lv, C., Zhang, X., Zhang, Y., Zhang, Y., Zhao, R., Chen, Y., & Zhang, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10804769/v1
., B. (2026) · International journal of applied research · doi:10.22271/allresearch.2026.v12.i9b.14099
Vine, D. F., Moran, L., Teede, H. J., & Khomami, M. B. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100734
Shapla, M. F. A., Akter, S., Kabir, F., & Sarker, N. (2026) · The Planet · doi:10.5281/zenodo.22845244
Haque, S., Hossain, M. E., Ashraf, M., & Jawad, K. S. (2026) · Asia Pacific Journal of Cancer Research · doi:10.70818/apjcr.v03i01.078
Shirasath, K. R., Awathale, S. N., & Goyal, S. N. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.09.017
MOBILE HEALTH AND PEER SUPPORT NETWORKS IN PCOS SELF-MANAGEMENT: A NARRATIVE REVIEW
Kępa, W., Kadłuczka, J., Papuga, A., Grzymek, M., Pawlucka, A., Pawłucka, K., Bury, J., Kraska, K., Potoniec, J., Sobek, A., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6217
Cretu, A.-M., Oprea, O. G., Săvucă, A., Ciobîcă, A., & Doroftei, B. (2026) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2026.3.07
Cao, Y., 李朝英, Zhang, Y., Wen, Q., 施媛媛, Xie, J., & Zhang, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1925127
Dokras, A. (2026) · Fertility & Reproduction · doi:10.1142/s2661318226300102
Self-citationLatheef, N., Esakkimuthu, M., & Prem, S. M. (2026) · Journal of Community Mobilization and Sustainable Development · doi:10.5958/2231-6736.2026.00003.3
Jiao, H., Hua, G. U. O., & Liu, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1909495
Women’s Brain Health in the Era of Precision Neuroimaging
Murata, E. M., Grotzinger, H., Martínez‐Garcia, M., Heller, C., Carmona, S., Shanmugan, S., Pritschet, L., & Jacobs, E. G. (2026) · Biological Psychiatry · doi:10.1016/j.biopsych.2026.09.011
Plichtowicz-Kordowska, W., Stępka, A., Jaworowicz, L., Jóźwicka, A., Janikowski, W., Lewandowska, K., & Bąkowska, E. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6207
SÍNDROME DOS OVÁRIOS POLICÍSTICOS: IMPACTOS METABÓLICOS, INFERTILIDADE E ABORDAGENS TERAPÊUTICAS
Batista, A. L. M., de Souza, I. C. B., dos Santos, C. V. P., Melo, A. C., dos Santos, J. G., Neto, T. F., da Silva, I. N., & de Souza, M. M. M. (2026) · Asclepius International Journal of Scientific Health Science · doi:10.70779/aijshs.v5i9.704
Yaga Jeyanthi., M., Sailatha, R., & Jayanthi, P. (2025) · International Journal of Environmental Sciences · doi:10.64252/2v8qqm76
Israr, S., Rahman, S., Kumari, D., Zeb, R., Ayyaz, H., & Rizvi, M. B. (2026) · Pakistan Journal Of Neurological Surgery
Il valore diagnostico dell'ormone antimulleriano (AMH) nella sindrome dell'ovaio policistico (PCOS).
de Dominicis, A. (n.d.) · Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila
Tauseef, U., Farook, F., Shetty, V. J., Ramos-Ocola, E., Premkumar, C. R., Haider, M., Gandhi, A., Shingala, T. S., Singh, S., TAHIR, M. M., et al. (2026) · Reproductive Medicine · doi:10.3390/reprodmed7040055
The Effect of Women's Awareness on the Prevention and Management of Polycystic Ovarian Syndrome
Hameed, H. R., Radi, A. F. N., Abd, H. N., Qassim, E. S., Razaq, F. C., Ali, S. H., HAMEEDAWİ, M. H. A. A., Kadush, A. J., & Jrood, D. F. (2026) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.24200/jogcr.11.12.1177
Ashraf, A., Naz, M., & Idrees, M. (2026) · Journal for Current Sign
李红涛, Yin, T., Wang, Y., Wang, Y., Xu, N., Yi, W., & Yang, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1978249
Effectiveness of Pilates Versus Multimodal Training in Women with Polycystic Ovarian Syndrome (PCOS)
Jeevitha, D. (2026) · Journal of chemical health risks
Kar, E., Yeh, J., Efe, M. A., Çelik, H. G., Bozdağ, G., & Baştu, E. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115499
The Role of Probiotics as Adjunctive Therapy in the Treatment of Depressive Disorders
Lopez, M. (n.d.) · Digital Commons - Gardner-Webb University (Gardner–Webb University)
Akhee, H. H., & Onty, A. N. (2026) · International Journal of Biological and Pharmaceutical Sciences Archive · doi:10.53771/ijbpsa.2026.12.2.0081
Yadav, A., Mishra, A., Sharma, A., & Singh, A. P. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179450
Cardozo, L. L. Y., Eissa, M., Basnet, J., Thompson, K., & Romero, D. G. (2026) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2026.10.006
Keskin, İ. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1018274
Bacușcă, E. D., Bacușcă, A. E., Bacușcă, A. I., Coșovanu, E. T., Popa, E., Petroaie, A. D., Slănină, A. M., Manole, M., & Coman, E. A. (2026) · Healthcare · doi:10.3390/healthcare14213635
Eating disorders and gynecological consequences
de Faria, I. M. A. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Síndrome dos Ovários Policísticos: Estratégias Terapêuticas Contemporâneas Além do Manejo Metabólico
Saba, R. R., da Costa, J. M. F., Cremasco, L. M., & Abrão, F. (2026) · doi:10.66396/hmc.v5.c13
Akter, A., Bosu, S., Hossain, M. A., Kathe, A. S., Akter, M. S., Eti, R. A., Suvo, S. S., Sarkar, B., Barsha, B. I., Shanto, M. H. I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11000266/v1
Global landscape and structural gaps in clinical trials for polyendocrine metabolic ovarian syndrome
Wang, J., Hao, D., & Zhang, Y. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2026.10.003
Qi, J., Zhu, M., & Zou, X. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1919067
Vuyyuru, P., Rani, R. T. G., Chide, S., Ramakuri, K., Achanta, R., Oggu, P., Kumari, B. V., & Praveena, G. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.86s.95
Khan, F., Govender, N., Mzimela, V., & Thandar, Y. (2026) · Current Psychology · doi:10.1007/s12144-026-10248-9
Women's Health and Challenges: What Can You Do?
Harris, K., Ofori, A. N., Jackson, N., Ashirifi, G. D., & Strachan, C. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-5111-5.ch004
Diagnosis and Multidisciplinary Management of Polyendocrine Metabolic Ovarian Syndrome
Valdez‐Sinon, A. N., Hosseinzadeh, P., & Moragianni, V. A. (2026) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2026.08.004
Examining the Association Between PCOS Symptoms and Depression Severity
Lee, J. (2026) · ScholarWorks (Walden University)
Antonio, A. A., & Rodríguez, D. A. A. (2026) · Revista Tópicos · doi:10.70773/revistatopicos/794528134
Hasan, M., Sultana, S., Sohan, M., Parvin, S., Rahman, M. A., Hossain, M. J., Rahman, M. S., & Islam, M. R. (2022) · doi:10.1371/journal.pone.0270102.r001
Wang, J., Fiori, P. L., Capobianco, G., Carru, C., & Chen, Z. (2024) · doi:10.3389/fendo.2024.1275419.s001
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.